P
The startup has developed a biological assay automation platform that streamlines the testing of 3D cell models, organoids, and spheroids for applications in oncology, neuroscience, and drug discovery. This technology enhances laboratory efficiency by enabling faster data collection and analysis, facilitating the development of therapeutics and diagnostic tests.
Updated 3 months ago
Funding
$4.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a biological assay automation platform that streamlines the testing of 3D cell models, organoids, and spheroids for applications in oncology, neuroscience, and drug discovery. This technology enhances laboratory efficiency by enabling faster data collection and analysis, facilitating the development of therapeutics and diagnostic tests.